When to Intervene for Subclinical Cushing's Syndrome.

Without the overt clinical signs and symptoms associated with Cushing's syndrome, the diagnosis of subclinical Cushing's syndrome (SCS) is primarily based on biochemical evaluation. Despite being labeled as "subclinical," SCS is associated with significant morbidity that can be improved with adrenalectomy. Minimally invasive adrenalectomy is associated with low morbidity in the hands of experienced adrenal surgeons and is recommended as the treatment of choice for SCS patients with SCS-associated comorbidities.

• Publication year

  2019

• Venue

  Surgical Clinics of North America

• Publication date

  2019-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.SUC.2019.04.011PMID 31255204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines on the management of adrenocortical carcinoma in adults , in collaboration with the European Network for the Study of Adrenal Tumors

  2018cited by this paper
• Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing’s syndrome and others with incidentalomas and subclinical hypercortisolism

  2018cited by this paper
• New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.

  2018cited by this paper
• European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors.

  2018cited by this paper
• Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism

  2017cited by this paper
• Six controversial issues on subclinical Cushing’s syndrome

  2017cited by this paper
• Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center

  2017cited by this paper
• Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

  2016cited by this paper
• MECHANISMS IN ENDOCRINOLOGY: Endogenous subclinical hypercortisolism and bone: a clinical review.

  2016cited by this paper
• Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.

  2016cited by this paper
• The Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome

  2016cited by this paper
• THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis.

  2016cited by this paper
• Subclinical hypercortisolism: a state, a syndrome, or a disease?

  2015cited by this paper
• Update on subclinical Cushing's syndrome

  2015cited by this paper
• Systematic review of surgical treatment of subclinical Cushing's syndrome

  2015cited by this paper
• Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes

  2015cited by this paper
• Subclinical Cushing syndrome: a review.

  2014cited by this paper
• Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.

  2014cited by this paper
• Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.

  2014cited by this paper
• Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.

  2014cited by this paper
• The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.

  2013cited by this paper
• Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome.

  2012cited by this paper
• Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.

  2012cited by this paper
• Subclinical Cushing’s syndrome: definition and management

  2012cited by this paper
• Outcomes after laparoscopic adrenalectomy

  2011cited by this paper
• Diagnosis and Treatment of Subclinical Hypercortisolism

  2011cited by this paper
• Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study

  2011cited by this paper
• AME position statement on adrenal incidentaloma.

  2011cited by this paper
• The diagnosis of Cushing’s syndrome

  2010cited by this paper
• Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas.

  2010cited by this paper
• Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

  2010cited by this paper
• Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

  2009cited by this paper
• The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.

  2009cited by this paper
• Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis.

  2009cited by this paper
• Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

  2009cited by this paper
• Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome.

  2008cited by this paper
• Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus.

  2008cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome.

  2007cited by this paper
• Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

  2005cited by this paper
• Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma.

  2005cited by this paper
• Subclinical Cushing's syndrome in adrenal incidentalomas.

  2005cited by this paper
• Prevalence and natural history of adrenal incidentalomas.

  2003cited by this paper
• Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes.

  2003cited by this paper
• Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.

  2002cited by this paper
• NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").

  2002cited by this paper
• Long-term follow-up study of patients with adrenal incidentalomas.

  2002cited by this paper
• Bone loss rate in adrenal incidentalomas: a longitudinal study.

  2001cited by this paper
• Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.

  2001cited by this paper
• Subclinical Cushing's syndrome.

  2000cited by this paper
• Risk factors and long-term follow-up of adrenal incidentalomas.

  1999cited by this paper
• Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours

  1998cited by this paper
• High fluid intake increases urine free cortisol excretion in normal subjects.

  1998cited by this paper
• Morbidity and mortality in Cushing's disease: an epidemiological approach

  1994cited by this paper
• The natural history of Cushing's syndrome.

  1952cited by this paper

• The impact of mild autonomous cortisol secretion and proposed interventions

  2025cites this paper
• An Analysis of Post-Adrenalectomy Dynamics in MACS (Mild Autonomous Cortisol Secretion)-Positive Adrenal Tumours: The Biomarkers and Clinical Impact

  2025cites this paper
• Evaluating the efficacy of surgical and conservative approaches in mild autonomous cortisol secretion: a meta-analysis

  2024cites this paper
• Clinical manifestations of functionally autonomous cortisol secretion in patients with adrenal masse

  2023cites this paper
• Association of chronic central serous chorioretinopathy with subclinical Cushing's syndrome

  2022cites this paper
• Cushing Syndrom

  2021cites this paper
• Differential dignosis: „primary“ or secondary diabetes - should Cushing´s syndrome be routinely screened in the patients with type 2 diabetes mellitus?

  2021cites this paper
• Adrenal Incidentaloma: A Review for Primary Care

  2021cites this paper
• Prophylactic Adrenalectomy

  2021cites this paper
• Robotic adrenalectomy for functional adenoma in second trimester treats worsening hypertension.

  2020cites this paper
• Hormonal Evaluation of Incidental Adrenal Masses: The Exception, Not the Rule

  2020cites this paper